65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05398809 (ClinicalTrials.gov)	January 18, 2023	26/5/2022	Evaluate the Efficacy and Safety of Ruxolitinibon Hair Regrowth in Patients With Autoimmune Polyendo ...	A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of Ruxolitinibon Hair Regrowth in Pat ...	Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced);Alopecia Areata	Drug: Ruxolitinib	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Recruiting	12 Years	65 Years	All	70	Phase 2	United States

First Previous1Next Last